Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.32% | -13.79% | -19.89% | -5.24% | -0.12% |
| Total Depreciation and Amortization | 12.75% | 9.54% | -10.23% | -24.54% | -37.83% |
| Total Amortization of Deferred Charges | 9.40% | 7.15% | 7.15% | 7.15% | 7.15% |
| Total Other Non-Cash Items | 133.12% | 74.36% | -58.59% | -99.15% | -82.18% |
| Change in Net Operating Assets | -90.63% | 54.25% | 89.01% | 54.89% | -221.31% |
| Cash from Operations | -26.14% | 130.50% | 212.24% | 35.77% | -27.95% |
| Capital Expenditure | 11.15% | 9.13% | 10.43% | 7.93% | 3.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 101.83% | -228.21% | -259.51% | -256.77% | -209.86% |
| Divestitures | -100.00% | -109.02% | -95.49% | -- | -- |
| Other Investing Activities | -159.07% | 152.68% | 172.74% | 172.85% | 119.64% |
| Cash from Investing | 73.99% | 24.40% | 45.85% | 41.38% | 7.27% |
| Total Debt Issued | -22.43% | 194.31% | 90.86% | 360.60% | 174.12% |
| Total Debt Repaid | -54.80% | -771.53% | -1,749.72% | -656.81% | -10.97% |
| Issuance of Common Stock | -63.35% | -84.08% | -61.84% | -28.64% | 45.39% |
| Repurchase of Common Stock | 12.30% | -87.52% | -25.34% | -22.97% | -8.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.39% | -2.97% | -4.89% | -6.47% | -8.10% |
| Other Financing Activities | 1,000.00% | -72.73% | -270.00% | -277.78% | -71.43% |
| Cash from Financing | -245.68% | 7.06% | -150.58% | 73.15% | 135.62% |
| Foreign Exchange rate Adjustments | 16.67% | -333.33% | 112.50% | -150.00% | -500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -130.00% | -114.29% | -- | -- |
| Net Change in Cash | -31.73% | 127.74% | 159.04% | 132.53% | 304.65% |